Condition: Persisent Atrial Fibrillation · Reversal of Atrial Enlargement · Recurrence of Atrial Fibrillation · Sponsor: The Second Affiliated Hospital of Chongqing Medical University
Electrical/pharmacological cardioversion improves structural remodeling of left atrium. We hypothesize that persistent atrial fibrillation (AF) patients with more significant left atrial size reduction after cardioversion have lower AF recurrence rates following radiofrequency ablation. The aim is to evaluate the relationship between changes in left atrial size 3 to 6 months after cardioversion and the recurrence rate of atrial fibrillation following radiofrequency ablation.
This description comes directly from the study's public registry record.
Yuehui Yin, MD · +8613508335502 · yinyh@hospital.cqmu.edu.cn; yinyh63@163.com
Fang Qin, MD · +8617308351199 · qinfangheart@126.com
Always discuss trial participation with your own doctor first.
| The Second Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06523738